Gene · 4591
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design, Synthesis, and Biological Activity Evaluation of Quinazoline-Based PLK4 Inhibitors. | Biomedicines | 2026 | 42652193 | PubTator, text mining | PubMed |
| Genome-wide association study of egg numbers across different laying phases in a large-scale layer population. | Br Poult Sci | 2026 | 42615881 | PubTator, text mining | PubMed |
| TRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration. | Cell Res | 2026 | 42533095 | PubTator, text mining | PubMed |
| The METTL3/TRIM37 axis contributes to the progression of non-alcoholic fatty liver disease by promoting CAV1 degradation. | Mol Cell Biochem | 2026 | 42484789 | PubTator, text mining | PubMed |
| Discovery of ZSL-M028: A Potent, Selective and Orally Available Quinazoline-Based PLK4 Inhibitor Targeting TRIM37-Amplified Neuroblastoma. | J Med Chem | 2026 | 42463132 | PubTator, text mining | PubMed |
| A simple and versatile fluorescence-based method to enhance prime editing in human pluripotent stem cells. | BMC Methods | 2026 | 42453142 | PubTator, text mining | PubMed |
| DHODH Drives Sunitinib Resistance Via a Non-Enzymatic Mechanism by Inhibiting TRIM28 Ubiquitination and Consequent VEGFA Activation in RCC. | Adv Sci (Weinh) | 2026 | 42335405 | PubTator, text mining | PubMed |
| Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification. | Cancer Cell Int | 2026 | 42316241 | PubTator, text mining | PubMed |
| TRIM37 interacts with PTEN to promote progression of hepatocellular carcinoma cells by modulating AKT/GSK-3β/β-Catenin pathway. | Transl Cancer Res | 2026 | 42305509 | PubTator, text mining | PubMed |
| PFN1 inhibits lytic replication of Kaposi sarcoma-associated herpesvirus through SQSTM1/p62-mediated selective autophagy targeting the KSHV helicase. | Autophagy | 2026 | 42260986 | PubTator, text mining | PubMed |
| Centrosome depletion rewires mitosis to impose dependence on the AURKA-TPX2 axis. | bioRxiv | 2026 | 42146378 | PubTator, text mining | PubMed |
| Impact of Chromosomal Instability and Aneuploidy in Cancer Development. | Annu Rev Cancer Biol | 2026 | 42137044 | PubTator, text mining | PubMed |
| Mulibrey Nanism: Clinical Spectrum and Molecular Pathogenesis. | Int J Mol Sci | 2026 | 42123650 | PubTator, text mining | PubMed |
| TRIM37-Mediated Ubiquitination and Degradation of KMT2D Activates JAK2-STAT3 Signaling to Promote Diffuse Large B-Cell Lymphoma Progression. | Hematol Oncol | 2026 | 42010975 | PubTator, text mining | PubMed |
| ALKBH5/IGF2BP1-mediated m6A demethylation of TRIM37 promotes pancreatic cancer tumorigenesis and glycolysis by mediating RBMX degradation. | Cell Biol Toxicol | 2026 | 41922631 | PubTator, text mining | PubMed |
| Novel Missense Variants in TRIM37 Associated with Mulibrey Nanism and Complex Congenital Heart Disease. | Cardiol Cardiovasc Med | 2026 | 41907767 | PubTator, text mining | PubMed |
| Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation. | Signal Transduct Target Ther | 2026 | 41872160 | PubTator, text mining | PubMed |
| IGF2BP3-TRIM37-P53 axis promotes tumor progression in LUAD. | Cell Signal | 2026 | 41831816 | PubTator, text mining | PubMed |
| CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae. | Front Cell Infect Microbiol | 2026 | 41756785 | PubTator, text mining | PubMed |
| STOML2 promotes hepatocellular carcinoma cell proliferation, invasion and migration by activating the PI3K/AKT signaling pathway (Review). | Oncol Lett | 2026 | 41743019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4591/papers